News

Revance announces addition of fintech platform for aesthetic practices with acquisition of HintMD

Jul 29, 2020

Dustin S. Sjuts of Revance Therapeutics: Five Things You Need To Know To Succeed In The Modern Beauty Industry Learn More

Jul 27, 2020

Neurology Live

DaxibotulinumtoxinA Aims to Be Next Big Post-Stroke Spasticity Treatment Learn More

Jul 23, 2020

Revance Completes Previously Announced Acquisition of HintMD and its Proprietary Fintech Platform for Aesthetic Practices Learn More

Jun 30, 2020

Revance Announces Last Patient Enrolled in Modified JUNIPER Phase 2 Upper Limb Spasticity Trial of DaxibotulinumtoxinA for Injection Learn More

Jun 30, 2020

Revance Announces Positive Results in Two Phase 2a Studies of DaxibotulinumtoxinA For Injection for the Treatment of Forehead Lines and Crow’s Feet, Respectively Learn More

Jun 1, 2020

Revance and Mylan to Advance Development Program for Biosimilar to BOTOX® Learn More

Feb 6, 2020

Revance Announces U.S. FDA Acceptance of Biologics License Application (BLA) for DAXI to Treat Glabellar (Frown) Lines Learn More

Jan 13, 2020

DERMATOLOGY TIMES

Revance to introduce TEOXANE RHA® fillers in the U.S. Learn More

Jan 10, 2020

PRACTICAL DERMATOLOGY

Revance Acquires Exclusive US Distribution Rights to Teoxane SA Fillers Learn More

Jan 10, 2020

Revance Announces Transformative Aesthetics Portfolio Transaction with Exclusive U.S. Distribution Agreement of FDA-Approved Dermal Fillers from TEOXANE SA Learn More

Jan 9, 2020

Revance Provides Corporate Update and Anticipated Milestones for 2020 Learn More

Job Opportunities

Do you have what it takes to join our team? Check out our Careers page and find out.

Search Jobs

Latest News:

Job Opportunities

Aesthetics

Therapeutics

Investors

Company

Careers